<p>Thiotepa is indicated, in combination with other chemotherapy medicinal products:</p>

<ul>
	<li>With or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;</li>
	<li>When high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.</li>
</ul>